Reporter June 14 2019

New method tested to block chikungunya infection

Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.

Stephan Heckers, MD, MSc, said the gift will allow VUMC to map the trajectory of psychosis.

$10 million gift bolsters psychosis research efforts

A $10 million endowed gift will fund translational research, support clinical programs and create an endowed chair within the Department of Psychiatry.

Eng named to GI cancer leadership position at VICC

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).

Diversity of conference attendees mirrors increasing support for palliative care

More than 80 people attended a Palliative Care Conference in Nashville recently that was led by faculty members of the Palliative Care programs at VUMC and the Nashville VA Medical Center, and VUMC Center for Biomedical Ethics.

From left, Alexander Gelbard, MD, Suman Das, PhD, and Simon Mallal, MBBS, are among a team of researchers searching for the cause of a rare airway disease that almost exclusively affects adult, Caucasian women.

Study seeks to expand treatment options for rare airway disease

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.

1 2